BioMarin Pharmaceutical Inc. buy Piper Sandler
Start price
23.02.24
/
50%
€84.34
Target price
23.02.25
€98.83
Performance (%)
-12.90%
Price
05.08.24
€73.46
Summary
This prediction is currently active. The prediction for BioMarin Pharmaceutical Inc. disappoints with a performance of -12.90%. This prediction currently runs until 23.02.25. The prediction end date can be changed by Piper_Sandler at any time. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
BioMarin Pharmaceutical Inc. | -0.950% | -0.950% |
iShares Core DAX® | -3.935% | -3.998% |
iShares Nasdaq 100 | -3.608% | -9.386% |
iShares Nikkei 225® | -4.513% | -8.017% |
iShares S&P 500 | -2.607% | -4.265% |
Comments by Piper_Sandler for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its price target lowered by analysts at Piper Sandler from $115.00 to $107.00. They now have an "overweight" rating on the stock.
Ratings data for BMRN provided by MarketBeat